Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes

Hanaa Reyad Abdallah; Eman Refaat Youness; Manar Maher Bedeir; Marwa W Abouelnaga; Wafaa M Ezzat; Yasser Elhosary; Hazem Mohamed El-Hariri; Mona Abd Elmotaleb A Hussein; Heba R Ahmed; Rasha Eladawy

doi:10.1186/s13098-023-01029-6

Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes

Diabetol Metab Syndr. 2023 Mar 21;15(1):52. doi: 10.1186/s13098-023-01029-6.

Affiliations

¹ Biological Anthropology Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt. [email protected].
² Medical Biochemistry Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt.
³ Child Health Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt.
⁴ Internal Medicine Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt.
⁵ Community Medicine Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt.
⁶ National Institute of Diabetes and Endocrinology, Cairo, Egypt.
⁷ Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Abstract

Background: Type 1 diabetes mellitus (T1DM) patients are at an increased risk for non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate the clinical criteria associated with the diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) among T1DM Egyptian children and adolescents.

Methods: 74 T1DM patients aged 8-18 year were enrolled in this cross sectional study. Assessments of Clinical status, anthropometric measures, lipid profile, glycated haemoglobin (HbA1c) and liver enzymes were done. Abdominal Ultrasound evaluation of hepatic steatosis was done. Accordingly, patients were divided into two groups (NAFLD and normal liver group) and compared together. Assessment of liver fibrosis using acoustic radiation force impulse elastography (ARFI) was done. Statistical analysis included; independent t-test, Chi square and Fisher's Exact, Pearson and Spearman tests and Logistic regression models for factors associated with fatty liver were used when appropriate.

Results: In this study; 74 patients were enrolled; 37 males (50%) and 37 females with mean age 14.3 ± 3.0 year. The mean insulin dose was 1.1 ± 0.4 U/kg and mean disease duration was 6.3 ± 3.0 year. NAFLD was detected in 46 cases while 28 cases had normal liver as diagnosed by abdominal ultrasound. Cases with NAFLD had statistically significant higher BMI-Z scores, waist/hip, waist/height and sum of skin fold thicknesses compared to those with normal liver (P < 0.05). The mean value of HbA1c % was significantly higher in NAFLD group (P = 0.003). Total cholesterol, triglycerides and LDL serum levels were significantly elevated (p < 0.05), while the HDL level was significantly lower in NAFLD cases (p = 0.001). Although, serum levels of liver enzymes; ALT and AST were significantly higher among cases with NAFLD than in normal liver group (p < 0.05), their means were within normal. Using the ARFI elastography; NAFLD cases exhibited significant fibrosis (F2, 3 and 4). BMI, patient age and female gender were among risk factors for NAFLD.

Conclusions: NAFLD represents a serious consequence in type 1 diabetic children and adolescents that deserves attention especially with poor glycemic control. NAFLD has the potential to evolve to fibrosis. This study demonstrated a very high prevalence of NAFLD in T1D children and adolescents using US which was (62.2%) with the percent of liver fibrosis among the NAFLD cases (F2-F4) using ARFI elastography was 26%. BMI, age of patients and female gender were detected as risk factors for NAFLD.

Keywords: Acoustic radiation force impulse elastography (ARFI); Anthropometric measures; Hepatopathy; Non-alcoholic fatty liver disease (NAFLD); Type1 diabetes.